Fundraising Fox
Rhaeos
Evanston, US · Founded 2018 · Delaware corporation · 16 employees on LinkedIn · 4 known investors
Find your way into Rhaeos
Sign up to see every warm intro you have to Rhaeos
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Rhaeos team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Rhaeos develops FlowSense, a noninvasive wireless wearable skin patch that monitors fluid flow in the body, initially targeting hydrocephalus patients who depend on implantable shunts for cerebrospinal fluid management.
Founders & leadership
Rhaeos was founded in 2018 by Dr. Chad Webb, John A. Rogers, Roozbeh Ghaffari, and Anna Lisa Somera.
Investors · 4
How we know: Creative Ventures's portfolio page · a partner's Signal profile · funding news · the VCSheet dataset · Not right? Tell us
How we know: Portal Innovations's portfolio page · Not right? Tell us
How we know: Steele Foundation for Hope's portfolio page · Not right? Tell us
How we know: funding news · Not right? Tell us
Funding
SEC filings, press & company announcements$6.2M disclosed across 1 of 2 rounds · 2021–2023
- Undisclosed amountSeed RoundDec 2021Source ↗
▶$6.2MraisedMar 2023 · 23 investors · Other Health CareRule 506(b)
- Chad SeaverDirector
- John A. RogersExecutive Officer, Director
- R. Chad WebbExecutive Officer, Director
- Roozbeh GhaffariDirector
- Anna Lisa SomeraExecutive Officer
- Adam ZyskExecutive Officer
- Offering amount
- $13M
- Amount sold
- $6.2M
- First sale
- Feb 2023
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
3 people who came through Rhaeos went on to found or lead other companies.
Non-dilutive funding · 4 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2022 | $3.1M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2021 | $1M |
| National Science Foundation | Phase II | 2021 | $978.6K |
| National Science Foundation | Phase I | 2020 | $225K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does Rhaeos do?
- Rhaeos develops FlowSense, a noninvasive wireless wearable skin patch that monitors fluid flow in the body, initially targeting hydrocephalus patients who depend on implantable shunts for cerebrospinal fluid management.
- Who founded Rhaeos?
- Rhaeos was founded by Dr. Chad Webb, John A. Rogers, Roozbeh Ghaffari, Anna Lisa Somera in 2018.
- Who are Rhaeos's investors?
- Rhaeos's investors include Creative Ventures, Portal Innovations, Steele Foundation for Hope, Lateral Capital.
- How much funding has Rhaeos raised?
- Rhaeos has disclosed $6.2M raised across 1 of its 2 known rounds.
- Where is Rhaeos headquartered?
- Rhaeos is headquartered in Evanston, US.